Jeremie Calais, Director, Clinical Research Program at UCLA Nuclear Medicine and Theranostics, shared a post on LinkedIn:
“This year, ASCO26 (Chicago) and SNMMI26 (Los Angeles) overlapped on the same dates. Please, not again.
I was invited to speak at both, and I attended both. It was great to connect, engage, meet, and learn about the new science and updates of our field at both events.
However, to the conference organizers: please, do not do this again.
Putting the two most important meetings for Theranostics on overlapping dates prevents building bridges between our specialties, and it isn’t doing anyone (or the planet) any favors.
Nuclear Medicine, Theranostics, and Medical Oncology are completely interconnected. Collaboration across our fields is what’s best for the patients we treat. We need more medical oncologists at SNMMI and more nuclear medicine physicians at ASCO.
We need Medical Oncology and #Nuclear Medicine in the same room, not 3000 km apart.
Our patients, and our carbon footprint, will thank you.”
Other articles featuring Jeremie Calais on OncoDaily.